What’s New

News
RNS60 Promotes Mitochondrial Biogenesis in Neurons
A team of scientists at Rush University in Chicago published a new study demonstrating increased formation of mitochondria and increased ATP production in neuronal cells treated with RNS60. This effect...
Read more
News
FDA Grants Revalesio Orphan Drug Status for ALS Investigational Drug RNS60
TACOMA, Wash. – September 20, 2017 – Revalesio announced today that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for the investigational drug RNS60 for the treatment...
Read more